Advances in stroke pharmacology

Zhenhua Zhou(Loma Linda University Medical Center), Jianfei Lu(Shanghai Jiao Tong University), Wen-Wu Liu(Second Military Medical University), Anatol Manaenko(Friedrich-Alexander-Universität Erlangen-Nürnberg), Xianhua Hou(Army Medical University), Qiyong Mei(Second Military Medical University), Junlong Huang(Shanghai Jiao Tong University), Jiping Tang(Loma Linda University), John H. Zhang(Loma Linda University), Honghong Yao(Southeast University), Qin Hu(Shanghai Jiao Tong University)
Pharmacology & Therapeutics
May 25, 2018
10.1016/j.pharmthera.2018.05.012
Cited by 164

Abstract

Related Papers

Live to die another way: modes of programmed cell death and the signals emanating from dying cells
Yaron Fuchs, Hermann Steller|Nature Reviews Molecular Cell Biology|2015|643
Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Trial: Protocol for a Randomized, Controlled, Multicenter Study Comparing the Solitaire Revascularization Device with IV tPA with IV tPA Alone in Acute Ischemic Stroke
Jeffrey L. Saver, Mayank Goyal, Alain Bonafé et al.|International Journal of Stroke|2015|278
Excessive Autophagy Contributes to Neuron Death in Cerebral Ischemia
Ruo‐Yang Shi, Jiequn Weng, Ling Zhao et al.|CNS Neuroscience & Therapeutics|2012|264
Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.
Julio Herrero García, K F Liu, Jane K. Relton|PubMed|1995|244
An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy
Matthew J. During, C. Wymond Symes, P. Lawlor et al.|Science|2000|221